enGene Therapeutics Inc. (ENGN): 8-K/A filed Jun 18, 2026

Form type

8-K/A

Filing date

Jun 18, 2026

Accession number

0001193125-26-275815

Filer

enGene Therapeutics Inc. (CIK 1980845)